Can I access the American Gene Technologies® treatment outside of the U.S.?

American Gene Technologies is currently in a Phase 1 trial of its HIV gene therapy that is U.S.-only. If it is successful, we hope to expand internationally for future trials and commercialization.

We are not a large pharmaceutical company, so our first human trial is only being conducted at local test sites in the Maryland/D.C. area in the U.S. We will try to partner with a large pharma after this trial to facilitate the next steps in the regulatory process (phases 2 and 3, approvals, etc.), which may entail a larger geographic area for further clinical trials. Should this treatment gain approval, we will work hard to get it distributed worldwide as quickly as possible.